INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $235,000 | -23.7% | 4,911 | +0.4% | 0.00% | -100.0% |
| Q1 2020 | $308,000 | -50.4% | 4,893 | -2.4% | 0.00% | 0.0% |
| Q4 2019 | $621,000 | +186.2% | 5,014 | +53.1% | 0.00% | – |
| Q3 2019 | $217,000 | -96.3% | 3,276 | -95.5% | 0.00% | -100.0% |
| Q2 2019 | $5,827,000 | -43.5% | 73,229 | -20.6% | 0.01% | -47.8% |
| Q1 2019 | $10,320,000 | +36.9% | 92,259 | +23.3% | 0.02% | +15.0% |
| Q4 2018 | $7,541,000 | -27.9% | 74,815 | -9.6% | 0.02% | -20.0% |
| Q3 2018 | $10,458,000 | +63.9% | 82,761 | +8.8% | 0.02% | +47.1% |
| Q2 2018 | $6,380,000 | +41.0% | 76,038 | +3.4% | 0.02% | +41.7% |
| Q1 2018 | $4,525,000 | +1.4% | 73,561 | -3.7% | 0.01% | -14.3% |
| Q4 2017 | $4,464,000 | +1541.2% | 76,412 | +3302.1% | 0.01% | +1300.0% |
| Q2 2017 | $272,000 | – | 2,246 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |